Jeff Geschwind, MD is the scientific mind behind Cage Pharma. His research focuses on disrupting cancer's energy supply by targeting tumor glycolysis. This innovative approach to cancer metabolism aims to develop novel, effective pharmaceutical options for patients facing complex cancer diagnoses. https://about.me/jeff.geschwind